Nicox SA NICXF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
5.30UNCH (UNCH)
52 week range
4.23 - 6.46

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.30
  • 52 Week High6.46
  • 52 Week High Date11/30/20
  • 52 Week Low4.23
  • 52 Week Low Date04/13/20
  • Market Cap186.26M
  • Shares Out37.03M
  • 10 Day Average Volume320
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change21.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.66
  • P/E (TTM)-8.04
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Nicox SA News

There is no recent news for this security.

Latest NICXF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Nicox SA is a France-based international ophthalmic company. It is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute...
Michele Garufi
Chairman
Gavin Spencer
Executive Vice President
Michael Bergamini
Executive Vice President
Emmanuelle Pierry
General Counsel
Address
Drakkar 2 - Batiment D
2405 route des Dolines
CS 10313 Sophia Antipolis
Valbonne
06560
France